Literaturquellen

1  Arbeitsgemeinschaft Diabetes und Schwangerschaft der Deutschen Diabetes-Gesellschaft: Diagnostik und Therapie des Gestationsdiabetes. Richtlinien der Deutschen Diabetes-Gesellschaft. Frauenarzt. 1993;34:13-14 .

2  Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop Conference on Gestational Diabetes mellitus. Diabetes Care. 1998;16 (21 suppl. 2):B161-B167.

3  Tamas G, Kerenyi Z. Gestational diabetes: current aspects on pathogenesis and treatment.Exp Clin Endocrinol Diabetes. 2001;109 (suppl.2):400-11 .

4  Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. J Am Med Assoc. 1993;269(5):609–615.

5  Statistisches Bundesamt (Hrsg.): Gesundheitsbericht für Deutschland. Metzler, Stuttgart. 1999:237-242 .

6  Kuhl C.Etiology and pathogenesis of gestational diabetes. Diabetes Care. 1998 ;(suppl.2):B19-26.

7  Xiong X, Bian X, Huang X. Observation of the long-term serum insulin level in women with gestational diabetes history. Zhonghua Fu Chan Ke Za Zhi. 1999;34(8):465-6.

8  Kumakura S, Maddux BA, Sung CK. Overexpression of membrane glycoprotein PC-1 can influence insulin action at post-receptor site. J Cell Biochem. 1998;68(3):366-377.

9  Tomazic M , Janez A, Sketelj A, Kocijancic A, Eckel J, Sharma PM. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus. Diabetologia. 2002;45(4):502-8.

10  Pérez-Jiménez F , López-Miranda J, Pinillos MD, Gómez P, Paz-Rojas E, Montilla P, Marín C, Velasco MJ, Blanco-Molina A, Jiménez Perepérez JA, Ordovás JM. A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia. 2001;44(11):2038-2043.

11  Ramachandran A, Snehalatha C, Kapur A,Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Jyotsna D. High prevalence of diabetes and impaired glucose tolerance in India. Diabetologia. 2001;44(9):1094-1101.

12  Kerenyi Z, Tabak AG, Stella P, Bosnyak Z, Simon K, Karadi I, Tamas G.Association between socioeconomic factors and the metabolic syndrome in women with prior gestational diabetes mellitus. Diabetes Care. 2000;23(9):1444-1445.

13  Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, Chatzianagnostou K, Bottone P, Teti G, Del Prato S, Benzi L. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract. 2003;62(2):131.

14  Bühling KJ, Sidor J, Kemper I, Dudenhausen JW. Gestationsdiabetes: Screening , oraler Glukosetoleranztest und Blutzuckertagesprofil. Dtsch Med Wochencshrift. 2003;128(25-26):1408-1411.

15  Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal Age and Screening for Gestational Diabetes, A Population Based Study. Obstet Gynecol. 1989;73(4):557-561.

16  Weiss PA, Walcher W, Scholz H. Der vernachlässigte Gestationsdiabetes: Risiken und Folgen. Geburtsh Frauenheilk. 1999;59:535-544.

17  Weiss P. Diabetes in pregnancy: Lessons from the fetus. In: Dornhorst A, Hadden D: Diabetes and Pregnancy: An international Approach to Diagnosis and Management, Wiley, Chichester. 1996:221-240.

18  Shushan A, Ezra Y, Samueloff A.Early treatment of gestational diabetes reduces the rate of fetal macrosomia. Am J Perinatol. 1997;14(5):253-256.

19  Drexel H, Bichler A, Sailer S, Breier C, Lisch HJ, Braunsteiner H, Patsch JR.Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus. Diabetes Care. 1988;11(10):761-768.

20  Salzberger M, Liban E. Diabetes and antenatal fetal death. Isr J Med Sci. 1975;1(6)1:623-628.

21  Damm P, Kuhl C, Hornnes P, Molsted-Pedersen L. A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care. 1995;18(5):654-665.

22  Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Molsted-Pedersen L, Hornnes P, Locht H, Pedersen O, Damm P. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care. 2004;27(5):1194-1199.

23  Damm P.Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull. 1998;45(5):495-509.

24  O'Sullivan J. The Boston Gestational Diabetes Studies: Review and Perspectives. In: Sutherland H, Stowers J, Pearson D: Carbohydrate Metabolism in Pregnancy and the Newborn IV. Springer, London. 1989:287-294.

25  Major C, DeVeciana M. Recurrence of gestational diabetes: Who is at risk? Am J Obstet Gynecol. 1998;179(4):1038-1042.

26  Persson B, Hanson U, Hartling SG, Binder C.Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes. 1991;40(suppl.2):136-141.

27  O'Sullivan JB. Body weight and subsequent diabetes mellitus. JAMA. 1982;248(8):949-952.

28  Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991;165(4):914-919.

29  Catalano PM, Bernstein IM, Wolfe RR, Srikanta S, Tyzbir E, Sims EA. Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol. 1986;155(6):1255-62.

30  Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L.Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol. 1992;167(3):607-16.

31  Dornhorst A, Paterson C., Nicholls JS, Wadsworth J, Chiu DC, Elkeles RS, Johnston DG, Beard RW. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Medicine. 1992;9(9):820-825.

32  Oats JJN. Fourth International Workshop-Conference on Gestational Diabetes Mellitus: overview and commentary on first session. Diabetes Care. 1998;21(suppl.2):B58-59.

33  Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes. 1999;48(4):848-854.

34  Damm P, Vestergaard H, Kuhl C, Pedersen O.Impaired insulin-stimulated nonoxidative glucose metabolism in glucose-tolerant women with previous gestational diabetes. Am J Obstet Gynecol. 1996;174(2):722-9.

35  Bergman RN, Ader M, Hücking K, Van Citters G. Accurate Assessment of ß-Cell Function. Diabetes. 2002;51(suppl.1):212-220.

36  Basu R, Breda E, Oberg AL, Powell CC, Man CD, Basu A, Vitton JL, Klee GG, Arora P, Jensen MD, Toffolo G, Cobell C, Rizza RA. Mechanisms of the Age-Associated Deterioration in Glucose Tolerance. Diabetes. 2003;52(7):1738-1748.

37  Freinkel N. Banting Lecture 1980. Of Pregnancy and progeny. Diabetes. 1980;29(12):1023-1035.

38  Whitaker RC, Pepe MS, Seidel KD, Wright JA, Knopp RH. Gestational diabetes and the risk of offspring obesity. Pediatrics. 1998;101(2):E9.

39  Silverman B, Landsberg L, Metzger B. Fetal hyperinsulinism in offspring of diabetic mothers: association with the subsequent development of childhood obesity. Ann N Y Acad Sci. 1993;699:36-45.

40  Seidman DS, Laor A, Stevenson DK, Sivan E, Gale R, Shemer J. Macrosomia does not predict overweight in late adolescence in infants of diabetic mothers. Acta Obstet Gynecol Scand. 1998;77(1):58-62.

41  Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and Obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care. 1993;16(1):310-314.

42  Plagemann A. Fetal Programming and functional teratogenesis: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks. J Perinat Med. 2004;32(4):297-305.

43  Gunderson EP. Intensive nutrition therapy for gestational diabetes. Diabetes Care. 1997;20(2):221-226.

44  Wang Y, Storlien LH, Jenkins AB, Tapsell LC, Jin Y, Pan JF, Shao YF, Calvert GD, Moses RG, Shi HL, Zhu XX.Dietary variables and glucose tolerance in pregnancy. Diabetes Care. 2000;23(4):460-464.

45  American Diabetes Association: Gestational Diabetes mellitus. Diabetes Care. 2001;24(suppl.1):77-79.

46  Langer O.When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2002;11(4):218-25.

47  Langer O.Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus. Diabetes Care. 1998;11(3):263-268.

48  Homko CJ, Reece EA.Self-monitoring of blood glucose in gestational diabetes. J Matern Fetal Neonatal Med. 2002;12(6):389-95.

49  Fontaine P. Self-monitoring of blood glucose in gestational diabetes mellitus. Diabetes Metab. 2003;29(2):S37-41.

50  Thomas-Dobersen D. Nutritional Management of Gestational Diabetes and Nutritional Management of Women With a History of Gestational Diabetes: Two Different Therapies or the Same? Clinical Diabetes. 1999;17(4):1556-64.

51  Jovanovic-Peterson L, Durak EP, Peterson CM. Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am J Obstet Gynecol. 1989;161(2):415-419.

52  Arbeitsgemeinschaft Diabetes u. Schwangerschaft der DDG: Die ärztliche Betreuung der schwangeren Diabetikerin. Diabetologie Informationen der Deutschen Diabetes-Gesellschaft. 1997;4:275-281.

53  Schäfer U, Songster G. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol. 1997;177(5):1165-1171.

54  Schäfer-Graf U. Betreuung von Neugeborenen diabetischer Mütter. Frauenarzt. 2003;44(4):439-441.

55  Langer O. A spectrum of glucose thresholds may effectively prevent complications in the pregnant diabetic patient. Semin Perinatol. 2002;26(3):196-205.

56  Biessels GJ, van der Heide LP, Kamal A, Bleys R, Gispen WH . Ageing and Diabetes. European Journal of Pharmacology. 2002;441(1-2):1-14.

57  MacLeod KM, Hepburn DA, Deary IJ, Goodwin GM, Dougall N, Ebmeier KP, Frier BM. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia.Diabetologia. 1994;37(3):257–263.

58  Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke. 1987;18(1):52-58.

59  McCall AL. The Impact of Diabetes on the CNS. Diabetes. 1992;41(5):557-570.

60  Foster JK, Lidder PG, Sünram SI. Glucose and memory: fractionation of enhancement effects. Psychopharmacology. 1998;137(7):259-270.

61  Korol DL, Gold PE. Glucose, Memory and Ageing. Am J Clin Nutr. 1998;67(suppl.):764-771.

62  Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends in Neuroscience. 2000;23(11):542-549.

63  Arvanitakis Z, Wilson RD, Bienias JL, Evans DA, Bennett DA. Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitice Function. Arch Neur. 2004;61(5):661-666.

64  Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in Cognitive Function by Glucose Tolerance Status in Older Adults. a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med. 2004;164(12):1327-33.

65  Messier C, Tsiakas M, Gagnon M, Desrochers A, Awad N. Effect of age and glucoregulation on cognitive performance. Neurobiology of Ageing. 2003;24(7):985-1003.

66  Vanhanen M, Koivisto K, Kuusisto J, Mykkänen L, Helkala EL, Hänninen T, Riekkinen P, Soininen H, Laakso M. Cognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance. Diabetes Care. 1998;21(3):398-402.

67  Awad N, Gagnon M, Desrochers A, Tsiakas M, Messier C. Impact of peripheral glucoregulation on memory. Behav Neurosci. 2002;116(4):691-702.

68  Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagago-Jack A, Alderson A. Memory Improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiol Ageing. 1996;17(1):123-130.

69  Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL. Improving Influence of Insulin on Cognitive Functions in Humans. Neuroendocrinology. 2001;74(4):270-280.

70  Biessels GJ, Bravenboer B, Gispen WH. Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease. European Journal of Pharmacology. 2004;490 (1-3):1-4. doi:10.1016/j.ejphar.2004.02.057 .

71  Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease. Neurology. 1998;50(1):164-168.

72  Elias PK, Elias MF, D'Agostino RB. NIDDM and blood pressure as risk factors for poor cognitive functioning. The Framingham Study. Diabetes Care. 1997;20(9):1388-1395.

73  Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD, Cherrier MR, Lofgreen C, Latendresse S, Petrova A, Plymate S, Raskind M, Grimwood K, Veith RC. Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose. Arch Gen Psychiatry. 1999;56(12):1135-1140. http://archpsyc.ama-assn.org/cgi/content/abstract/56/12/1135.

74  Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, Alkon DL. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. Neuroscience Letters. 1996;208(1):53-56.

75  Palovcik AR, Phillips MI, Kappy MS, Mohan K, Raizada. Insulin inhibits pyramidal neurons in hippocampal slice. Brain Research.1984;309(1):187-191. doi:10.1016/0006-8993(84)91028-X.

76  Baskin DG, Figlewicz DP, Woods SC, Porte D, Dorsa DM. Insulin and the brain. Annu Rev Psychol. 1987;49(3):335-347.

77  Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, Fehm HL, Peters A. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. Journal of Clinical Endocrinology and Metabolism2002;87(2):835-840.doi:10.1210/jc.87.2.835.

78  Peters A, Schweiger U, Frühwald-Schultes B, Born J, Fehm HL. The neuroendocrine control of glucose allocation. Exp Clin Endocrinol Diabetes. 2002;110(5):199-211.

79  Kimura T, Takamatsu J, Ikeda K, Kondo A,Miyakawa T, Horiuchi S. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neuroscience Letters. 1996;208(1):53-56.

80  Li YM, Dickson DW. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease. Neurosci Lett. 1997;226(3):155-158.

81  Kumari M, Brunner E, Fuhrer R. Minireview: Mechanisms by Which the Metabolic Syndrome and Diabetes Impair Memory. Journal of Gerontology Series A: Biological Sciences and Medical Sciences. 2000;55(5):B228-B232.

82  Asimakopoulou KG, Hampson SE, Morrish NJ. Neuropsychological functioning in older people with Type II diabetes:the effect of controlling for confounding factors. Diabetic Medicine. 2002;19(4):311-316.

83  Gold PE. Role of glucose in regulating the brain and cognition. American Journal of Clinical Nutrition. 1995;61(suppl.4):987-995.

84  Donohoe RT, Benton D. Glucose tolerance predicts performance on tests of memory and cognition. Physiology and Behaviour. 2000;71(3-4):395-401.

85  Welsh B, Wecker L. Effects of Streptozotocin-induced diabetes on acetylcholine metabolism in rat brain. Neurochem Res. 1991;16(4):453-460.

86  Harik SI, Gravina SA, Kalaria RN. Glucose transporter of the blood-brain barrier and brain in chronic hyperglycemia. J Neurochem. 1988;51(6):1930-1934.

87  Gjedde A, Crone C. Blood-brain glucose transfer: repression in chronic hyperglycemia. Science. 1981;214(4519):456-457.

88  Hasselbalch SG, Knudsen GM, Capaldo B, Postiglione A, Paulson OB. Blood-Brain Barrier Transport and Brain Metabolism of Glucose during Acute Hyperglycemia in Humans. J Cl End Met. 2001;86(5):1986-1990.

89  Stewart R, Liolitsa D. Type 2 Diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 1999;16(2):93-112.

90  Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type 2 Diabetes associated with an increased risk of cognitive dysfunction? A critical Review of published studies. Diabetes Care. 1997; 20(3):438-445.

91  Convit A, Wolf OT, Tarshish C, de Leon MJ. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci. 2003; 100(4):2019-2022.

92  Mankovsky BN. Cerebrovascular disorders in patients with diabetes mellitus. J. Diabet. Complic. 1997;10(4):228–242.

93  Levy J, Gavin JR, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Neuroendocrinology. 1994;96(3):260-273.

94  Biessels GJ, Ter Laak AP, Hamers F, Gispen WH. Neuronal Ca 2+ disregulation in diabetes mellitus. Eur J Pharmacol. 2002;447(2-3):201-209.

95  Spinedi E, Gaillard RC. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin. J Endocrinol Invest. 1991;14(7):551–557.

96  Ockenfels JS, Porter L, Kirschbaum C, Hellhammer DH, Stone AA. Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. Psychoneuroendocrinology. 1998;23(4):353-370. doi:10.1016/S0306-4530(98)00008-0.

97  Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH. Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci. 1996;58(17):1475-83.

98  Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994;19(4):313-33.

99  Kirschbaum C, Hellhammer DH. Salivary cortisol in psychobiological research: an overview Department of Clinical and Physiological Psychology, University of Trier. Neuropsychobiology. 1989;22(3):150-69.

100  Seeman TE, McEwen BS, Singer BH, Alber MS, Rowe JW. Increase in Urinary Cortisol Excretion and Memory Declines: MacArthur Studies of successful Ageing. J Clin Endocrinolo Metab. 1997;82(8):2458-2465.

101  Sandeep TC, Yau JL, MacLullich AM, Noble J, Deary IJ, Walker BR, Seckl JR. 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci. 2004;101(17):6734-6739.

102  Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5(1):25–44.

103  Horner HC, Packan DR, Sapolsky RM. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology. 1990;52(1):57-64.

104  de Leon MJ, McRae T, Rusinek H, Convit A, De Santi S, Tarshish C, Golomb J, Volkow N, Daisley K, Orentreich N, McEwen B. Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab. 1997;82(10):3251-3259.

105  Sturm W, Herrmann, Wallesch. Lehrbuch der klinischen Neurpsychologie, Aufgaben und Strategien der neuropsychologischen Diagnostik, 2000.

106  Lezak MD. Neuropsychological Assessment, New York, 2nd edition, Oxford University Press, 1983.

107  Llorente, Vizcano A, Cejudo-Bolivar JC. Memories and Alzheimer's disease. Rev Neurol. 2001;32(12):1163-72.

108  Koss E. Neuropsychology an Alzheimer's disease. Clin Geriatr Med. 1994;10(2):299-313.

109  Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Ten-Point Clock Test: a correlation analysis with other neuropsychological tests in dementia. Int J Geriatr Psychiatry. 2002;17(4):347-53.

110  Andres P, Van der Linden M. Are central executive functions working in patients with focal frontal lesions? Neuropsychologia. 2002;40(7):835-45.

111  Arbizu J, Larumbe R, Gamez C, Marti J, Martinez-Lage J, Richter J. Correlations between brain SPECT and neuropsychology assessments in mild and moderate stages of Alzheimer's disease. Rev Esp Med Nucl. 1999;18(4):252-60.

112  Robbins TW, Elliott R, Sahakian BJ. Neuropsychology-dementia and affective disorders. Br Med Bull. 1996;52(3):627-43.

113  Miller EN, Satz P, Visscher B. Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology. 1991;41(10):1608-16.

114  Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8.

115  Björntorp P, Holm E, Rosmond R. Hypothalamic arousal, Insulin resistance and Type 2 diabetes mellitus. Diabet Med. 1999;16(5):373-83.

116  Delaney RC, Prevey ML, Cramer J, Mattson RH. Test-retest comparability and control subject data for the Rey-Auditory Verbal Learning Test and Rey-Osterrieth/Taylor Complex Figures.Arch Clin Neuropsychology. 1992;7(6):523-528.

117  Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press, 1998.

118  Amodio P, Wenin H, Del Piccolo F, Mapelli D, Montagnese S, Pellegrini A, Musto C, Gatta A, Umilta C. Variabilitiy of Trail making Test, symbol digit Test and line trait test in normal people. A normative Study taking into account age-dependent decline and sociobiological variables. Ageing Clin Exp Res. 2002;14(2):117-131.

119  Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail making Test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996;17(4):305-309.

120  Martin TA, Hoffmann NM, Donders J. Clinical Utility of the trail making test ratio score. Appl Neuropsychology. 2003;10(3):163-169.

121  Daniels C, Witt K, Wolff S, Jansen O, Deuschl G. Rate dependency of the human cortical network subserving executive functions during generation of random number series – a functional magnetic resonance imaging study. Neuroscience Letters. 2003;345(1):25–28.

122  Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the Validity of the Beck Depression Inventory. Psychopathology. 1998;31(3):160–168.

123  Endler NS, Rutherford A, Denisoff E. Beck Depression inventory: exploring its dimensionality in a nonclinical population. J Clin Psychol. 1999;55(10):1307-1312.

124  Shenal BV, Harrison DW, Demaree HA. The Neuropsychology of Depression: A Literature Review and Preliminary Model. Neuropsychology Review. 2003;13(1):33-42.

125  MacLeod C, Mathews A. Cognitive-experimental approaches to the emotional disorders. In Martin PR: Handbook of behavior therapy and psychology science: an integrative approach. Oxford: Pergamon Press, 1991.

126  Hessel A, Schumacher J, Geyer M, Brähler E. Symptom-Checkliste SCL-90-R: Testtheoretische Überprüfung und Normierung an einer bevölkerungsrepräsentativen Stichprobe. Diagnostica. 2000;47:27-49.

127  Balkau B, Eschwége E, Papoz L, Richard JL, Claude JR, Warnet JM, Ducimetière P. Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ. 1993;307(6899):295-299.

128  Pyörälä K, Laakso M, Uusitupa M. Diabetes and artherosclerosis: an epidemiological view. Diabetes Metab Rev. 1987;3(2):463-524.

129  Kenny S, Aubert R, Geiss L. Prevalence and incidence of non-insulin-dependent diabetes, Diabetes in America, 2nd Edition. Bethesda, MD: NIH Publication. 95–1468;47–68,1995.

130  Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol. 1998;147(6):574–580.

131  Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, Sturis J. Defects in Insulin Secretion and Action in Women with a History of Gestational Diabetes. Diabetes. 1995;44(5):506-512.

132  Andrews RC, Herlihy O, Livingstone DEW, Andrew R, Walker B. Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance. J Clin Endocrinol Metab. 2002;87(12):5587-5593.

133  Erlanger DM, Kutner KC, Jacobs AR. Hormones and Cognition: Current Concepts and Issues in Neuropsychology. Neuropsychology Review. 1999;9(4):175-206.

134  Varghese FP, Brown ES. The Hypothalamic-Pituitary Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians. Primary Care Companion. J Clin Psychiatry. 2001;3(4):151-155.

135  Lindeman RD, Romero LJ, LaRue A, Yau CL, Schade DS, Koehler KM, Baumgartner RN, Garry PJ. A Biethnic Community Survey of Cognition in Participants With Type 2 Diabetes, Impaired Glucose Tolerance, and Normal Glucose Tolerance. Diabetes Care. 2001;24(9):1567-1572.

136  Leung HC, Skudlarski P, Gatenby JC, Peterson, BS, Gore JC. An Event-related Functional MRI Study of the Stroop Color Word Interference Task. Cerebral Cortex. 2000;10(6):552-560.

137  Petrides M, Alivisatos B, Frey S. Differential activation of the human orbital, mid-ventrolateral, and mid-dorsolateral prefrontal cortex during the processing of visual stimuli. Proc Natl Acad Sci. 2002;99(8):5649-5654.

138  Strenge H, Bohm J. Random Number Generation in native and foreign languages. Percept Mot Skills. 2004;98(3Pt2):1153-1161.

139  Horne RL, Evans FJ, Orne MT. Random number generation, psychopathology and therapeutic change. Arch Gen. Psychiatry. 1982;39(6):680–683.

140  Spatt J, Goldenberg G. Components of random generation by normal subjects and patients with dysexecutive syndrome. Brain Cogn. 1993;23(2):231-42.

141  Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Pyorala K, Riekkinen P, Laakso M. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension. 1993;22(5):771-779.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
11.12.2006